Back to All

Diaceutics CEO Keeling Provides Personalized Rx-Focused Consultant's View of Industry Progress

1 February, 2012

Gain insights into the diagnostic industry from Diaceutics CEO Peter Keeling. In this Q&A session, Keeling shares his personalized perspective on the evolving landscape of precision medicine and diagnostic testing.

From discussing the role of consultants in driving personalized treatment strategies to exploring the challenges and opportunities in the diagnostic industry, he provides invaluable insights for healthcare professionals, researchers, and industry stakeholders.

Whether you're seeking to understand the latest trends in precision medicine or looking for strategies to optimize diagnostic testing, this Q&A with Peter Keeling offers a wealth of knowledge and expertise. Dive into the full interview to uncover the insights that could shape the future of precision medicine.

Click here to view the full article

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane

Tel: +44 (0)20 3405 0205 or [email protected]

Caroline Forde
Robyn Fisher
Kieran Breheny